Skip to main content

ImageneBio, Inc.

IMA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001835579

In the last 90 days, ImageneBio, Inc. insiders filed 0 open-market purchases and 1 sale; 35 institutions reported holding it in 13F filings for Q2 2026, worth $36.8M in total; no superinvestor holds it.

Q2 2024 vs. Q1 2024

How the institutions holding ImageneBio, Inc. changed between Q1 2024 and Q2 2024.

All holders in Q2 2024All holders in Q1 2024

13F holders of IMA: Q1 2024 compared with Q2 2024
MeasureQ1 2024Q2 2024Change
Holders5770+13
Shares30.1M29.0M−1.09M (−3.6%)
Value$42.7M$47.9M+$5.12M (+12.0%)

New holders (28)

Institutions that held ImageneBio, Inc. at the end of Q2 2024 but not at the end of Q1 2024.

Institutions new to IMA in Q2 2024
InstitutionSharesValue% of portfolio
BML Capital Management, LLC585,114$965.4K0.71%
Millennium Management LLC354,710$585.3K0.00%
Susquehanna International Group, LLP83,218$137.3K0.00%
Deuterium Capital Management, LLC80,578$133.0K0.22%
Centiva Capital, LP73,431$121.2K0.01%
JBF Capital, Inc.72,647$119.9K0.02%
Alpine Global Management, LLC64,641$106.7K0.02%
Y-Intercept (Hong Kong) Ltd60,628$100.0K0.01%
Jane Street Group, LLC55,840$92.1K0.00%
Point72 Asia (Singapore) Pte. Ltd.45,520$75.1K0.02%
Qube Research & Technologies Ltd34,941$57.7K0.00%
Paloma Partners Management Co30,240$49.9K0.00%
Virtu Financial LLC28,053$46.0K0.00%
Squarepoint Ops LLC27,666$45.6K0.00%
HRT Financial LP26,893$44.0K0.00%
Corsair Capital Management, L.P.24,830$41.0K0.01%
AQR Capital Management LLC21,861$36.1K0.00%
Berkshire Asset Management LLC20,000$33.0K0.00%
BBR Partners, LLC20,000$33.0K0.00%
JustInvest LLC18,310$30.2K0.00%
Mirae Asset Global ETFs Holdings Ltd.16,270$26.8K0.00%
Cubist Systematic Strategies, LLC4,842$7.99K0.00%
Catalyst Funds Management Pty Ltd4,500$7.42K0.00%
Point72 (DIFC) Ltd4,392$7.25K0.00%
Russell Investments Group, Ltd.2,316$3.82K0.00%
Macquarie Group Ltd1,585$2.62K0.00%
SRS Capital Advisors, Inc.299$4940.00%
Nisa Investment Advisors, LLC99$1630.00%

Sold out (15)

Institutions that held ImageneBio, Inc. at the end of Q1 2024 and filed for Q2 2024 without it.